SUPERNUS PHARMACEUTICALS INC's ticker is and the CUSIP is 868459AB4. A total of 3 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $203,000 | +37.2% | 25,000 | 0.0% | 0.00% | – |
| Q1 2017 | $148,000 | +24.4% | 25,000 | 0.0% | 0.00% | – |
| Q4 2016 | $119,000 | +1.7% | 25,000 | 0.0% | 0.00% | – |
| Q3 2016 | $117,000 | +21.9% | 25,000 | 0.0% | 0.00% | – |
| Q2 2016 | $96,000 | +33.3% | 25,000 | 0.0% | 0.00% | – |
| Q1 2016 | $72,000 | +14.3% | 25,000 | 0.0% | 0.00% | – |
| Q4 2015 | $63,000 | -4.5% | 25,000 | 0.0% | 0.00% | – |
| Q3 2015 | $66,000 | -17.5% | 25,000 | 0.0% | 0.00% | – |
| Q2 2015 | $80,000 | – | 25,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 683 Capital Management, LLC | 6,600,000 | $16,038,000 | 6.11% |
| Perceptive Advisors | 2,915,000 | $6,650,000 | 0.52% |
| Tekla Capital Management LLC | 2,000,000 | $4,826,000 | 0.19% |
| WELLINGTON MANAGEMENT GROUP LLP | 170,000 | $410,000 | 0.00% |
| AMERIPRISE FINANCIAL INC | 217,000 | $524,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 50,000 | $121,000 | 0.00% |